Professor Manuel Kaulich is a biochemist and cell biologist at the Faculty of Medicine at the Goethe University in Frankfurt / Main. He is an expert in gene editing and functional genomics, with an interest in mapping the dependencies of cancer cells at scale and how technological and computational aspects enable these large investigations. Born in Berlin, Manuel studied and did his PhD and postdoc in Germany, Switzerland, and the United States, before starting his independent research group at Goethe University. Manuel is an inventor of gene editing technologies and the co-founder of the biotech company Vivlion GmbH that provides and supports CRISPR R&D at scale.
Login or Register
You need to be logged in to use this feature.
Further Activities to have a look at